-2.8

-2.9

NS

^a An improvement in score is indicated by a more negative change in the score.

^b To account for multiple analyses, appropriate statistical methods were applied and the required level of significance is 0.01.

NS=not significant.

One long-term, randomized, open-label multicenter concurrently controlled study, two long-term, open-label multicenter, historically controlled studies and one long-term, randomized, dose-response study were conducted to evaluate the efficacy of growth hormone for the treatment of patients with short stature due to Turner syndrome.

In the randomized study, GDCT, comparing growth hormone-treated patients to a concurrent control group who received no growth hormone, the growth hormone-treated patients who received a dose of 0.3 mg/kg/wk given 6 times per week from a mean age of 11.7 years for a mean duration of 4.7 years attained a mean near final height of 146.0 ± 6.2 cm (n=27, mean ± SD) as compared to the control group who attained a near final height of 142.1 ± 4.8 cm (n=19). By analysis of covariance* the effect of growth hormone therapy was a mean height increase of 5.4 cm (p=0.001).

In two of the studies (85-023 and 85-044), the effect of long-term growth hormone treatment (0.375 mg/kg/wk given either 3 times per week or daily) on adult height was determined by comparing adult heights in the treated patients with those of age-matched historical controls with Turner syndrome who never received any growth-promoting therapy. The greatest improvement in adult height was observed in patients who received early growth hormone treatment and estrogen after age 14 years. In Study 85-023, this resulted in a mean adult height gain of 7.4 cm (mean duration of GH therapy of 7.6 years) vs. matched historical controls by analysis of covariance.

In Study 85-044, patients treated with early growth hormone therapy were randomized to receive estrogen replacement therapy (conjugated estrogens, 0.3 mg escalating to 0.625 mg daily) at either age 12 or 15 years. Compared with matched historical controls, early GH therapy (mean duration of GH therapy 5.6 years) combined with estrogen replacement at age 12 years resulted in an adult height gain of 5.9 cm (n=26), whereas patients who initiated estrogen at age 15 years (mean duration of GH therapy 6.1 years) had a mean adult height gain of 8.3 cm (n=29). Patients who initiated GH therapy after age 11 (mean age 12.7 years; mean duration of GH therapy 3.8 years) had a mean adult height gain of 5.0 cm (n=51).

In a randomized blinded dose-response study, GDCI, patients were treated from a mean age of 11.1 years for a mean duration of 5.3 years with a weekly dose of either 0.27 mg/kg or 0.36 mg/kg administered 3 or 6 times weekly. The mean near final height of patients receiving growth hormone was 148.7 ± 6.5 cm (n=31). When compared to historical control data, the mean gain in adult height was approximately 5 cm.

In some studies, Turner syndrome patients (n=181) treated to final adult height achieved statistically significant average height gains ranging from 5.0 to 8.3 cm.

Table 3: Summary Table of Efficacy Results

Brand Name: Humatrope Generic Name: Somatropin rDNA Origin « Previous Clinical Pharmacology Next » Next: Humatrope - Patient Information » « Previous: Humatrope - Overdosage & Contraindications Report Problems to the Food and Drug Administration   You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. Bookmark this page: Privacy Policy Parenting and Pregnancy Get tips for baby and you. WebMD Resources Slideshow: Top 20 Baby Skin Problems Quiz: School Success With ADHD Help Your Child Beat Bedwetting Health Extras Test your Health IQ for a chance to win a Wii Fit from WebMD 2008 Election & Health Care on WebMD. Get Informed. Overscheduled Families Do you run your kids from one activity to another, day after day? If so, you should take a minute to watch.See more WebMD Videos » ADHD Symptom Control in Children for Up to 12 Hours Consider a Long-Acting Treatment Option for Children Download a Doctor Discussion Guide Get Up to $50 Off Your Child's First Prescription Humatrope Drug Description Indications & Dosage Side Effects & Drug Interactions Warnings & Precautions Overdosage & Contraindications Clinical Pharmacology Patient Information Health Resources Attention Deficit Hyperactivity Disorder (ADHD) Common Cold Diaper Rash Childhood Immunization (Vaccination) Flu (Influenza) Drug News Are Prostate Drugs Bad for Bones? New Warnings for Kids' Cough, Cold Drugs Spiriva Helps COPD Patients Breathe Better View More » Search the Medical Dictionary for Health Definitions & Medical Abbreviations Updated & New News & Features Identify Your Drugs: Use the RxList Pill Identification Tool Add RxList Search to Your Website Google Subscribed Links & RxList Popular Searches Adderall Aricept Avandia Botox Cardura Chantix Coumadin Levaquin OxyContin Viagra RxList Home|Drugs & Medications A-Z List |Picture Slideshows |Pill Identification Tool |Diseases & Conditions|Drug Medical Dictionary |Alternative Medicine About RxList|Contact RxList|Terms & Conditions|Privacy Policy|Sponsor Policy|Site Map WebMD®|MedScape®|eMedicineHealth®|MedicineNet® Copyright © 2008 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.